Sectors

China Life Private Equity Investment and PICC Capital returned to co-lead the pharmaceutical discovery technology provider’s latest rounds, four months after it emerged from stealth.

SoftBank Vision Fund 2 co-led the virtual avatar infrastructure builder’s $110m series C round, which emerged alongside a $20m series B featuring new and returning investors.

The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.

Mitsui took part in oncology therapy developer Ensem Therapeutics' $67m series A round while Bioventus is paying up to $450m to buy the rest of portfolio company CartiHeal.

The sports gear retailer has disclosed its largest round was led by the NFL and included the MLB, NHL and Paris Saint-Germain, at a $27bn valuation.

FTX Ventures took part in the cryptocurrency protocol developer’s latest round, which followed a $150m token sale three months ago.

The drug retailer’s AB Health Ventures unit will focus on early to mid-stage healthcare technology providers working on areas including pharmaceutical distribution, commercialisation and pet care.

Q&A with Meryem Aydin, senior investment analyst, Amadeus Ventures

The Stripe-backed rapid checkout tool developer was valued at $1bn early last year but is closing its doors after failing to raise more cash.

The gut microbiome drug developer went public in a $22.5m offering priced at the foot of its range.

The electronics subscription service received $110m in equity and $220m in debt financing from a consortium including Assurant, SevenVentures and Mirae Asset-LG Electronics New Growth Fund.